Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hodgkin Disease × Omeprazole × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Pancreatic Neoplasms 2 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Peripheral Nervous System Diseases 1 Obesity 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Inflammation 1 Hodgkin Disease 1 Healthy Adult Participants 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Chemotherapy Effect 1 Burkitt Lymphoma 1 Breast Neoplasms, Male 1 Advanced Solid Tumors 1

Interventions

Cyclophosphamide 31 Doxorubicin 20 pembrolizumab 19 fludarabine 18 Nivolumab 18 fludarabine phosphate 16 Vinblastine 16 Dacarbazine 16 Brentuximab Vedotin 16 Whole-Body Irradiation 15 Mycophenolic Acid 15 Etoposide 13 Melphalan 12 Filgrastim 11 Tacrolimus 10 Gemcitabine 10 Bleomycin 9 Rituximab 8 Radiotherapy 8 Granulocyte Colony-Stimulating Factor 8 Vincristine 7 Prednisone 7 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 pegfilgrastim 6 Stem Cell Transplantation 6 Magnetic Resonance Spectroscopy 6 Bendamustine Hydrochloride 6 Thiotepa 5 Specimen Handling 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06383338 2025-09-08

PEGASUS

Murdoch Childrens Research Institute

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡